Dr. Neelesh Reddy

Consultant

25 Years of Experience

Medical Oncologist

MBBS, MD, DM

Reg. No.:55636, Karnataka Medical Council

Manipal Hospital, Hebbal, Bangalore

Manipal Hospital, Millers Road, Bangalore

Manipal Hospital, Yeshwanthpur, Bangalore

English, Hindi, Kannada, Tamil

Consultation Fee ₹ 1000

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Neelesh Reddy

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

About Dr. Neelesh Reddy

Dr. Neelesh Reddy is a medical oncologist with about 25 years of experience.
He offers services such as mastectomy, hormone therapy for prostate cancer, brachytherapy (internal radiation therapy), external beam radiation for prostate cancer and gastrointestinal endoscopic mucosal resection.
He excels in the treatment of oral, lung, thoracic, gynecological, genitourinary, endometrial, breast, gastrointestinal and blood cancer. Specifically, he is experienced in acute lymphoblastic leukemia, cancer surgery, sinonasal malignancies and HPV vaccination.
His areas of special interest include internal medicine and hemato-oncology.
Dr. Reddy has experience in:
- Immunotherapy
- Chemotherapy of solid tumors
- Advanced therapies such as stem cells, ozone and growth factors
- Preventive cancer screening
- Osteosarcoma treatment
Dr. Neelesh Reddy did his MBBS from Kasturba Medical College in 1999. He further did his MD in General Medicine from Mahadevappa Rampure Medical College, Gulbarga, in 2004.
He also has a higher specialization with DM in Oncology from Adyar Cancer Institute, MGR University in 2008.
Dr. Reddy is also associated with international medical organizations, such as ESMO and ASCO.
He gave presentations on the topics, such as ‘Outcome of Acute Myocardial Infarction in Diabetics vs. Non-Diabetics’.
He also has published several research papers and articles on important topics in his field in reputed journals, like Cancer Research, Statistics, and Treatment, Indian Journal of Gynecologic Oncology, and many more.

Confirm Your Consultation With Dr. Neelesh Reddy

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS - Kasturba Medical College, 1999
MD - General Medicine - Mahadevappa Rampure Medical College, Gulbarga, 2004
DM - Oncology - Adyar Cancer Institute, MGR University, 2008

OPD Schedule Of Dr. Neelesh Reddy

Book Appointment

Past Experience

Consultant, Department of Oncology, Columbia Asia Hospital, Yeshwantpur and Whitefield
Consultant Medical Oncologist, HCG Bangalore, 2010

‘Best Outgoing Student Award’ - Adyar Cancer Institute, 2008
Topper - Final Examination of DM, Tamil Nadu Dr. MGR Medical University, Chennai, 2008
First prize - state-level quiz, KAPICON, 2004

Raheja, R., Reddy, N., Patel, T., Kilambi, S., Mathew, A. A., & Majeed, A. (2023). Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes. Cureus, 15(8).
Seshachalam, A., Saju, S. V., Raju, H. S., Rathnam, K., Janarthinakani, M., Prasad, K., ... & Raman, S. G. (2022). Outcome of COVID-19 in Indian patients with cancer: A multicenter, retrospective study. Cancer Research, Statistics, and Treatment, 5(1), 11-18.
Seshachalam, A., Karpurmath, S. V., Rathnam, K., Srinivasan, A., Scott, J., Raman, S. G., ... & Niraimathi, K. (2021). Role of interim PET scan after two cycles of ABVD in pediatric Hodgkin Lymphoma: Retrospective multicenter study from South India. Indian Journal of Medical and Paediatric Oncology, 42(05), 415-425.
Rathnam, K., Niraimathi, K., Shewade, H. D., Patil, C. N., Reddy, N., Ganapathy, R., ... & Seshachalam, A. (2020). Prognostic significance of molecular profile in non-metastatic invasive breast cancer: a multicentre study from India. Indian Journal of Gynecologic Oncology, 18, 1-11.
Reddy, N., Malipatil, B., & Kumar, S. (2016). A rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased propensity to cancers. Hematology/Oncology and Stem Cell Therapy, 9(4), 154-156.